Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
G protein-coupled receptor 119 agonist
Email alerts
G protein-coupled receptor 119 agonist
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study
Nobuya
Inagaki
,
Hubert S
Chou
,
Shuji
Tsukiyama
,
Takuo
Washio
,
Kazuhito
Shiosakai
,
Yasuhiko
Nakatsuka
,
Takashi
Taguchi
BMJ Open Diabetes Research and Care
Sep 2017,
5
(1)
e000424;
DOI:
10.1136/bmjdrc-2017-000424
Special collections
BMJ Open Diabetes Research and Care
Cardiovascular and metabolic risk
(31)
Clinical care/education/nutrition/psychosocial research
(56)
Emerging technologies and therapeutics
(6)
Epidemiology/health services research
(84)
Genetics/genomes/proteomics/metabolomics
(2)
Immunology and transplantation
(2)
Islet studies
(3)
Metabolism
(10)
Methodology review(s)
Obesity studies
(10)
Pathophysiology/complications
(24)
Pharmacology and therapeutics
(6)
Signal transduction
Technological advances
(1)
Guidelines, Recommendations and Consensus Statements
Press releases
(4)